Evidence map›Paper›PMID 35000022›Full record

SynthesisClinical and experimental medicine2023

Prognostic value of

Qian Li, Linhui Hu, Alice Charwudzi, Weiwei Zhu, Ye Meng, Zhimin Zhai

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Clinical and experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. The [European journal of nuclear medicine and molecular imaging · 2026
    Pooled it
  2. Baseline [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Review
  4. The Impact of Focal Lesions on Overall and Progression-free Survival in Multiple Myeloma.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Qian Li *Department of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Linhui HuDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Alice CharwudziDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Weiwei ZhuDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Ye MengDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China.
Zhimin ZhaiDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, 230601, Anhui Province, People's Republic of China. zzzm889@163.com.ORCID http://orcid.org/0000-0002-1990-4523
Anhui Medical University · CN

Funding

Anhui Science and Technology Department 201903a07020030National Natural Science Foundation of China 81670179
6 · The paper itself

Abstract

Multiple myeloma is a clonal B-lymphocyte tumor of terminally differentiated plasma cells.

Indexed as

Fluorodeoxyglucose F18Multiple MyelomaHumansPositron-Emission TomographyPositron Emission Tomography Computed TomographyPrognosisRadiopharmaceuticalsFluorodeoxyglucose F18RadiopharmaceuticalsMeta-analysisMultiple myelomaPositron emission tomography-computed tomographyPrognosis

Identifiers

PMID35000022
OpenAlexW4205759162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.